The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing

EMBO Journal

Volumn 18, Issue 12, 1999, Pages 3348-3358

  Waterman, Hadassa ^a   Alroy, Iris ^a   Strano, Sabrina ^a   Seger, Rony ^a   Yarden, Yosef ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cbl; Endocytosis; ErbB; Tyrosine kinase; Ubiquitin

Indexed keywords

CHIMERIC PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PROTEIN TYROSINE KINASE; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENDOCYTOSIS; LIGAND BINDING; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CELL DIVISION; CELL LINE; CELL SURVIVAL; DIMERIZATION; DOWN-REGULATION; ENDOCYTOSIS; EPIDERMAL GROWTH FACTOR; GLYCOPROTEINS; HUMANS; ISOENZYMES; MITOGENS; NEUREGULINS; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PROTEIN KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-3; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 0033564877     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.12.3348     Document Type: Article

References (62)

1. Alimandi, M., Romano, A., Curia, M.C., Muraro, R., Fedi, P., Aaronson, S.A., Di Fiore, P.P. and Kraus, M.H. (1995) Cooperative signaling of ErbB-3 and ErbB-2 in neoplastic transformation of human mammary carcinoma cells. Oncogene, 15, 1813-1821.
2. Alimandi, M. et al. (1997) Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. EMBO J., 16, 5608-5617.
3. Alroy, I. and Yarden, Y. (1997) The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Letts., 410, 83-86.
4. Barbacci, E.G., Guarino, B.C., Stroh, J.G., Singleton, D.H., Rosnack, K.J., Moyer, J.D. and Andrews, G.C. (1995) The structural basis for the specificity of epidermal growth factor and heregulin binding. J. Biol. Chem., 270, 9585-9589.
5. Baulida, J., Kraus, M.H., Alimandi, M., Di Fiore, P.P. and Carpenter, G. (1996) All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J. Biol. Chem., 271, 5251-5257.
6. Ben-Levy, R., Paterson, H.F., Marshall, C.J. and Yarden, Y. (1994) A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP-kinase pathway. EMBO J., 13, 3302-3311.
7. Bray, D. (1990) Intracellular signalling as a parallel distributed process. J. Theor. Biol., 143, 215-31.
8. Burden, S. and Yarden, Y. (1997) Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis. Neuron, 18, 847-855.
9. Carpenter, C.L. and Cantley, L.C. (1996) Phosphoinositide 3-kinase and the regulation of cell growth. Biochem. Biophys. Acta, 1288, M11-M16.
10. Carraway, K.L. and Cantley, L.C. (1994) A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling. Cell, 78, 5-8.
11. Chen, X. et al. (1996) An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4. J. Biol. Chem., 271, 7620-7629.
12. Cohen, B.D., Kiener, P.K., Green, J.M., Foy, L., Fell, H.P. and Zhang, K. (1996) The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH-3T3 cells. J. Biol. Chem., 271, 30897-30903.
13. Ebner, R. and Derynck, R. (1991) Epidermal growth factor and transforming growth factor-α: differential intracellular routing and processing of ligand-receptor complexes. Cell Regul., 2, 599-612.
14. Erickson, S.L., O'Shea, K.S., Ghaboosi, N., Loverro, L., Frantz, G., Bauer, M., Lu, L.H. and Moore, M.W. (1997) ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. Development, 124, 4999-5011.
15. Fedi, P., Pierce, J., Di Fiore, P.P. and Kraus, M.H. (1994) Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase Cγ or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members. Mol. Cell. Biol., 14, 492-500.
16. Fiddes, R.J., Campbell, D.H., Janes, P.W., Sivertsen, S.P., Sasaki, H., Wallasch, C. and Daly, R.J. (1998) Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3. J. Biol. Chem., 273, 7717-7724.
17. Galcheva-Gargova, Z., Theroux, S.J. and Davis, R.J. (1995) The epidermal growth factor receptor is covalently linked to ubiquitin. Oncogene, 11, 2649-2655.
18. Graus-Porta, D., Beerly, R., Daly, J.M. and Hynes, N.E. (1997) ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J., 16, 1647-1655.
19. Guy, P.M., Platko, J.V., Cantley, L.C., Cerione, R.A. and Carraway, K.L. (1994) Insect cell-expressed p180ErbB3 possesses an impaired tyrosine kinase activity. Proc. Natl Acad. Sci. USA, 91, 8132-8136.
20. Johansen, F.E. and Prywes, R. (1994) Two pathways for serum regulation of the c-fos response element require specific sequence elements and a minimal domain of serum response factor. Mol. Cell. Biol., 14, 5920-5928.
21. Joly, M., Kazlauskas, A., Fay, F.S. and Corvera, S. (1994) Disruption of PDGF receptor trafficking by mutation of its PI-3 kinase binding sites. Science, 263, 684-687.
22. Karunagaran, D., Tzahar, E., Beerli, R.R., Chen, X., Graus-Porta, D., Ratzkin, B.J., Seger, R., Hynes, N.E. and Yarden, Y. (1996) ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J., 15, 254-264.
23. Kim, H.H., Vijapurkar, U., Hellyer, N.J., Bravo, D. and Koland, J.G. (1998) Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein. Biochem. J., 334, 189-195.
24. Klapper, L.N., Kirschbaum, M.H., Sela, M. and Yarden, Y. (1999) Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. In Klein, G. and Woude, V. (eds), Advances in Cancer Research. Academic Press, in press.
25. Kornfeld, K. (1997) Vulval development in Caenorhabditis elegans. Trends Genet., 13, 55-61.
26. Levkowitz, G., Klapper, L.N., Tzahar, E., Freywald, A., Sela, M. and Yarden, Y. (1996) Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins. Oncogene, 12, 1117-1125.
27. Levkowitz, G., Waterman, H., Zamir, L., Kam, Z., Oved, S., Langdon, W.Y., Beguinot, L., Geiger, B. and Yarden, Y. (1998) c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev., 12, 3663-3674.
28. Marikovsky, M., Lavi, S., Pinkas-Kramarski, R., Karunagaran, D., Liu, N., Wen, D. and Yarden, Y. (1995) ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes. Oncogene, 10, 1403-1411.
29. Mosman, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63.
30. Mossie, K., Jallal, B., Alves, F., Sures, I., Plowman, G.D. and Ullrich, A. (1995) Colon carcinoma kinase-4 defines a new subclass of the receptor tyrosine kinase family. Oncogene, 11, 2179-2184.
31. Obermeier, A., Tinhofer, I., Grunicke, H.H. and Ullrich, A. (1996) Transforming potentials of epidermal growth factor and nerve growth factor receptors inversely correlate with their phospholipase Cγ affinity and signal activation. EMBO J., 15, 73-82.
32. Olayioye, M.A., Graus-Porta, D., Beerly, R.R., Rohere, J., Gay, B. and Hynes, N.E. (1998) ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner. Mol. Cell. Biol., 18, 5042-5051.
33. Peles, E., Ben-Levy, R., Tzahar, E., Liu, N., Wen, D. and Yarden, Y. (1993) Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships. EMBO J., 12, 961-971.
34. Pinkas-Kramarski, R. et al. (1996) Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J., 15, 2452-2467.
35. Pinkas-Kramarski, R. et al. (1998) The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin. Oncogene, 16, 1249-1258.
36. Prigent, S.A. and Gullick, W.J. (1994) Identification of c-erbB-3 binding sites for phosphatidylinositol 3′-kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO J., 13, 2831-2841.
37. Riethmacher, D., Sonnenberg, R.E., Brinkmann, V., Yamaai, T., Lewin, G.R. and Birchmeier, C. (1997) Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature, 389, 725-30.
38. Seger, R. and Krebs, E.G. (1995) The MAP kinase signaling cascade. FASEB J., 9, 726-735.
39. Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A. and McGuire, W.L. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-182.
40. Slamon, D.J. et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712.
41. Sliwkowski, M.X. et al. (1994) Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J. Biol. Chem., 269, 14661-14665.
42. Soltoff, S.P., Carraway, K.L., Prigent, S.A., Gullick, W.G. and Cantley, L.C. (1994) ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol. Cell. Biol., 14, 3550-3558.
43. Sorkin, A. and Waters, C.M. (1993) Endocytosis of growth factor receptors. BioEssays, 15, 375-382.
44. Sorkin, A., Di Fiore, P.P. and Carpenter, G. (1993) The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimera is internalization impaired. Oncogene, 8, 3021-3028.
45. Syroid, D.E., Maycox, P.R., Burrola, G.P., Liu, N., We, D., Lee, K.-F., Lemke, G. and Kilpatrick, T.J. (1996) Cell death in the Schwann cell lineage and its regulation by neuregulin. Proc. Natl Acad. Sci. USA, 93, 9229-9234.
46. Thien, C.B.F. and Langdon, W. (1998) c-Cbl: a regulator of T cell receptor-mediated signaling. Immunol. Cell Biol., 76, 473-482.
47. Tzahar, E. and Yarden, Y. (1998) The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands. BBA Rev. Cancer, 1377, M25-M37.
48. Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B.J. and Yarden, Y. (1996) A hierarchical network of inter-receptor interactions determines signal transduction by NDF/ neuregulin and EGF. Mol. Cell. Biol., 16, 5276-5287.
49. Tzahar, E. et al. (1997) Bivalency of EGF-like ligands drives the ErbB signaling network. EMBO J., 16, 4938-4950.
50. Tzahar, E. et al. (1998) Pathogenic poxvinises reveal viral strategies to exploit the ErbB signaling network. EMBO J., 17, 5948-5963.
51. van der Geer, P., Hunter, T. and Lindberg, R.A. (1994) Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol., 10, 251-337.
52. Vartanian, T., Goodearl, A., Viehover, A. and Fischbach, G. (1997) Axonal neuregulin signals through activation of HER4 and Schwann cells through HER2 and HER3. J. Cell Biol., 137, 211-220.
53. Vieira, A.V., Lamaze, C. and Schmid, S.L. (1996) Control of EGF receptor signaling by clathrin-mediated endocytosis. Science, 274, 2086-2088.
54. Vijapurkar, U., Cheng, K. and Koland, J.G. (1998) Mutation of a Shc binding site tyrosine residue in ErbB3/HER3 blocks heregulin-dependent activation of mitogen-activated protein kinase. J. Biol. Chem., 273, 20996-21002.
55. Wallasch, C., Weiss, F.U., Niederfellner, G., Jallal, B., Issing, W. and Ullrich, A. (1995) Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J., 14, 4267-4275.
56. Waterman, H., Sabanai, I., Geiger, B. and Yarden, Y. (1998) Alternative intracellular routing of ErbB receptors may determine signaling potency. J. Biol. Chem., 273, 13819-13827.
57. Wells, A., Welsh, J.B., Lazar, C.S., Wiley, H.S., Gill, G.N. and Rosenfeld, M.G. (1990) Ligand-induced transformation by a non-internalizing epidermal growth factor receptor. Science, 247, 962-964.
58. Whitmarsh, A.J., Shore, P., Sharrocks, A. and Davis, R.J. (1995) Integration of MAP kinase signal transduction pathways at the serum response element. Science, 269, 403-407.
59. Yano, S., Tokumitsu, H. and Soderling, T.R. (1998) Calcium promotes cell survival through CaM-K kinase activation of the protein kinase-B pathway. Nature, 396, 584-587.
60. Yoon, C.H., Lee, J., Jongeward, G.D. and Sternberg, P.W. (1995) Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-Cbl. Science, 269, 1102-1105.
61. Zhang, K., Sun, J., Liu, N., Wen, D., Chang, D., Thomason, A. and Yoshinaga, S.K. (1996) Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J. Biol. Chem., 271, 3884-3890.
62. Zhu, X., Lai, C., Thomas, S. and Burden, S.J. (1995) Neuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapses. EMBO J, 14, 5842-5848.